Perrigo | PRGO - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
AbbVie USD 9.39B 4.16B 2026-03
Abbott USD 6.8B 1.72B 2026-03
Bayer EUR 6.67B 774M 2025-12
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Coherus Biosciences USD 88.88M 14.47M 2025-12
Corcept Therapeutics USD 108.74M 11.76M 2026-03
Dr.Reddys Laboratories INR 18.66B 8.75B 2025-12
Eli Lilly USD 5.28B 1.99B 2026-03
J&J USD 21.69B 1.98B 2026-03
Merck USD 5.33B 9.24B 2026-03
Nestle CHF 4.58B 73M 2025-12
Pacira USD 144.31M 14.24M 2026-03
Perrigo USD 531.6M 99.5M 2025-12
Pfizer USD 1.7B 561M 2026-03
Phibro Animal Health USD 54.93M 557K 2026-03
Prestige Brands USD 63.87M 1.5M 2026-03
Reckitt Benckiser GBP 880M 106M 2024-12
Sanofi EUR 7.66B 1.25B 2025-12
Supernus Pharmaceuticals USD 184.87M 56.42M 2026-03
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Xeris Pharmaceuticals USD 111.75M 708K 2026-03
Zoetis USD 1.94B 369M 2026-03